![]() CIS CIS by Deloitte specializes in integrated compliance and commercial services for the life sciences and health care industry. We provide solutions that focus on risk mitigation and value-driven insight. | ![]() Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products. | ![]() Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | ||
Founding Date | Founding Date 2015 | Founding Date 1978 | Founding Date 1901 | Founding Date 1983 |
Type | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Newtown Square, US HQ Morrisville, US | Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more | Locations HQ | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more |
Employees | Employees 1334% decrease | Employees 9,500 | Employees 29,780 | Employees 43,000 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹582.2b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods N/A | Cost of goods ₹115.4b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $1.7b (FY, 2025) | Gross profit N/A | Gross profit ₹488.9b (FY, 2026) |
Net income | Net income N/A | Net income $407m (FY, 2025) | Net income N/A | Net income ₹115.6b (FY, 2026) |

Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
View company
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company